Taylor Pedersen
banner
taylorpedersen.bsky.social
Taylor Pedersen
@taylorpedersen.bsky.social
AD, sleep, and neuroimaging | clinical psych student @WashU in the Brian Gordon Lab | NSF GRFP | ISTAART Ambassador + Neuroimaging PIA | @UW + Iliff Lab alum 🧠🕺
Reposted by Taylor Pedersen
While we started to think about #AIC26, we thought we would remind anyone who either missed #AIC25 or would like to re-watch it: @emmacoomans.bsky.social Year in Review is available to watch on demand here: training.alz.org/products/489... 😊
@istaart.bsky.social
October 27, 2025 at 8:15 AM
Reposted by Taylor Pedersen
The FDA has cleared the first blood test for Alzheimer’s for use in primary care settings to rule out the presence of amyloid.

“This is another important step toward expanding access to Alzheimer’s diagnostic tools." -Joanne Pike, Association president & CEO

Read our full statement: bit.ly/4oh3Tiu
Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
Developed by Roche, this is the first blood test for use in primary care to rule out Alzheimer's-related amyloid pathology.
www.alz.org
October 13, 2025 at 9:14 PM
Reposted by Taylor Pedersen
Registration is open for AAIC Neuroscience Next, Feb. 23-26. This no-cost, global hybrid event is a great opportunity to collaborate and connect both in person and virtually around the globe! Learn more: alz.org/NeuroscienceNext. #AAICNeuro #ALZSky #NeuroSky
October 9, 2025 at 5:36 PM
Excited to share our newest publication! We examined the variability of sleep longitudinally in amyloid positive and negative individuals using both objective and subjective measures.

dx.doi.org/10.1002/alz....
Variability of longitudinal sleep monitoring in amyloid‐negative and amyloid‐positive cognitively unimpaired and mildly impaired older adults
INTRODUCTION Sleep disturbances are associated with Alzheimer's disease (AD) pathology and cognitive symptoms, but few studies have longitudinally assessed sleep, AD biomarkers, and cognition. Under.....
dx.doi.org
October 8, 2025 at 10:16 PM
Exciting news to start your Friday! The second Glymphatic Conference was just announced to be held at Oxford in 2026!

Also, give @glymphaticrnet.bsky.social a follow if you are an #ECR interested in studying the glymphatic system. It is a great new resource!
📅 Save the Date: Oxford 2026 Glymphatic Research Symposium!

• Dates: March 30th, March 31st, April 1st 2026.
• Keynote speakers: Maiken Nedergaard & Jonathan Kipnis.
• Venue: Keble College, Oxford, UK.
• Registration link to follow

Looking forward to seeing you there! 🧠
September 12, 2025 at 3:06 PM